Kazimir Sestanj

803 total citations
19 papers, 632 citations indexed

About

Kazimir Sestanj is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Kazimir Sestanj has authored 19 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Organic Chemistry. Recurrent topics in Kazimir Sestanj's work include Aldose Reductase and Taurine (7 papers), Chemical Synthesis and Analysis (4 papers) and Fluorine in Organic Chemistry (3 papers). Kazimir Sestanj is often cited by papers focused on Aldose Reductase and Taurine (7 papers), Chemical Synthesis and Analysis (4 papers) and Fluorine in Organic Chemistry (3 papers). Kazimir Sestanj collaborates with scholars based in United States and Canada. Kazimir Sestanj's co-authors include D. Dvornik, N. Simard-Duquesne, S.D. Varma, J. H. Kinoshita, Kenneth H. Gabbay, L Merola, H. Immer, Leslie G. Humber, Steven Fung and Adi M. Treasurywala and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Kazimir Sestanj

17 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazimir Sestanj United States	11	282	273	146	119	118	19	632
Charles E. Aldinger United States	10	288 1.0×	454 1.7×	101 0.7×	140 1.2×	116 1.0×	13	1.0k
Ikuo Hatanaka Japan	9	227 0.8×	168 0.6×	76 0.5×	243 2.0×	64 0.5×	17	598
Animesh Chandra United States	11	282 1.0×	352 1.3×	30 0.2×	174 1.5×	78 0.7×	16	648
Todd W. Siegel United States	9	148 0.5×	233 0.9×	57 0.4×	47 0.4×	56 0.5×	12	601
M Tsuboshima Japan	9	152 0.5×	109 0.4×	34 0.2×	163 1.4×	50 0.4×	12	443
Guy Augert France	13	69 0.2×	329 1.2×	64 0.4×	129 1.1×	23 0.2×	17	714
Mauro Miceli Italy	12	142 0.5×	92 0.3×	37 0.3×	98 0.8×	67 0.6×	13	420
Werner P. Dafeldecker United States	14	144 0.5×	204 0.7×	59 0.4×	36 0.3×	12 0.1×	18	560
Buichi Fujitani Japan	14	52 0.2×	224 0.8×	31 0.2×	70 0.6×	53 0.4×	46	649
R J Marchmont United Kingdom	9	58 0.2×	566 2.1×	59 0.4×	100 0.8×	26 0.2×	9	734

Countries citing papers authored by Kazimir Sestanj

Since Specialization

Citations

This map shows the geographic impact of Kazimir Sestanj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazimir Sestanj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazimir Sestanj more than expected).

Fields of papers citing papers by Kazimir Sestanj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazimir Sestanj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazimir Sestanj. The network helps show where Kazimir Sestanj may publish in the future.

Co-authorship network of co-authors of Kazimir Sestanj

This figure shows the co-authorship network connecting the top 25 collaborators of Kazimir Sestanj. A scholar is included among the top collaborators of Kazimir Sestanj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazimir Sestanj. Kazimir Sestanj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sestanj, Kazimir, et al.. (1994). Synthesis of epibatidine. Tetrahedron Letters. 35(30). 5417–5420. 31 indexed citations

Sestanj, Kazimir, et al.. (1991). Naphthalenylsulfonyl-hydantoins as aldose reductase inhibitors. European Journal of Medicinal Chemistry. 26(4). 369–374. 2 indexed citations

Sestanj, Kazimir, et al.. (1991). Synthesis and biological evaluation of tolrestat metabolites. European Journal of Medicinal Chemistry. 26(2). 197–200. 4 indexed citations

Wrobel, Jay, Arlene Dietrich, Beverly J. Gorham, & Kazimir Sestanj. (1990). Conformationally rigid analogs of aldose reductase inhibitor, tolrestat. Novel syntheses of naphthalene-fused .gamma.-, .delta.-, and .epsilon.-lactams. The Journal of Organic Chemistry. 55(9). 2694–2702. 26 indexed citations

Butera, John A., Jehan F. Bagli, Wendel W. Doubleday, et al.. (1989). Computer assisted design and synthesis of novel aldose reductase inhibitors. Journal of Medicinal Chemistry. 32(4). 757–765. 11 indexed citations

Wrobel, Jay, Jane Millen, Janet Sredy, et al.. (1989). Orally active aldose reductase inhibitors derived from bioisosteric substitutions on tolrestat. Journal of Medicinal Chemistry. 32(11). 2493–2500. 14 indexed citations

Sestanj, Kazimir, et al.. (1984). N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. Journal of Medicinal Chemistry. 27(3). 255–256. 107 indexed citations

Sestanj, Kazimir, F. Bellini, Steven Fung, et al.. (1984). ChemInform Abstract: N‐((5‐(TRIFLUOROMETHYL)‐6‐METHOXY‐1‐NAPHTHALENYL)THIOXOMETHYL)‐N‐METHYLGLYCINE (TOLRESTAT), A POTENT, ORALLY ACTIVE ALDOSE REDUCTASE INHIBITOR. Chemischer Informationsdienst. 15(32). 1 indexed citations

Varughese, Kottayil I., et al.. (1983). The crystal structure of N-[[6-methoxy-5-(trifluoromethyl)thio-1-naphthalenyl]thioxomethyl]-N-methylglycine, C₁₆H₁₄F₃NO₃S₂. Canadian Journal of Chemistry. 61(9). 2137–2140. 11 indexed citations

10.

Fung, Steven, et al.. (1983). Syntheses of 1-trifluoromethyl-2-naphthalenols via a novel construction of the naphthalene nucleus. Canadian Journal of Chemistry. 61(2). 368–371. 5 indexed citations

11.

Lippmann, W., et al.. (1976). Antagonism of prostaglandin-induced cyclic AMP accumulation in the rat anterior pituitary in vitro by somatostatin analogues. Cellular and Molecular Life Sciences. 32(8). 1034–1036. 12 indexed citations

12.

Borgeat, Pierre, Fernand Labrie, Jacques Drouin, et al.. (1974). Inhibition of adenosine 3′,5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone. Biochemical and Biophysical Research Communications. 56(4). 1052–1059. 109 indexed citations

13.

Immer, H., et al.. (1974). ChemInform Abstract: SYNTHESIS OF SOMATOSTATIN. Chemischer Informationsdienst. 5(27). 3 indexed citations

14.

Bélanger, Alain, Fernand Labrie, Pierre Borgeat, et al.. (1974). Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone. Molecular and Cellular Endocrinology. 1(5). 329–339. 43 indexed citations

15.

Immer, H., et al.. (1974). Synthesis of Somatostatin. Preliminary communication. Helvetica Chimica Acta. 57(3). 730–734. 22 indexed citations

16.

Immer, H., et al.. (1974). Luteinizing hormone-releasing hormone and analogs. Synthesis and biological activity. Journal of Medicinal Chemistry. 17(10). 1060–1065. 6 indexed citations

17.

Dvornik, D., N. Simard-Duquesne, Kazimir Sestanj, et al.. (1973). Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor. Science. 182(4117). 1146–1148. 224 indexed citations

18.

Kraml, M., Kazimir Sestanj, & D. Dvornik. (1971). Metabolism of the anticonvulsant 10, 11-dihydro-5H-dibenzo [a,d]cycloheptene-5-carboxamide—I. Biochemical Pharmacology. 20(9). 2327–2338. 1 indexed citations

19.

Sestanj, Kazimir. (1971). A Facile Formation of Dibenzo [a,d] cycloheptenylium Ion by Decarbonylation. Color Reactions of the Cyheptamide Metabolites. Canadian Journal of Chemistry. 49(4). 664–665.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact